Skip to content
10-Q

Quarterly Report

NEON THERAPEUTICS, INC.

0001694187-20-000041

← back to feed
Filed
May 1, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Apr 30, 2020 28.97M sh
Capex Q1 2020 · Mar 31, 2020 $9K
Capex Q1 2020 · Mar 31, 2019 $1.03M
Operating Cash Flow Q1 2020 · Mar 31, 2020 −$14.28M
Operating Cash Flow Q1 2020 · Mar 31, 2019 −$21.16M
Cash And Equivalents Q1 2020 · Mar 31, 2020 $15.05M
Cash And Equivalents Q1 2020 · Dec 31, 2019 $29.4M
Cash And Equivalents Q1 2020 · Mar 31, 2019 $49.26M
Stockholders Equity Q1 2020 · Mar 31, 2020 $14.43M
Stockholders Equity Q1 2020 · Dec 31, 2019 $29.42M
Stockholders Equity Q1 2020 · Mar 31, 2019 $82.07M
Stockholders Equity Q1 2020 · Dec 31, 2018 $101.25M
Current Liabilities Q1 2020 · Mar 31, 2020 $10.77M
Current Liabilities Q1 2020 · Dec 31, 2019 $10.41M
Total Liabilities Q1 2020 · Mar 31, 2020 $16.97M
Total Liabilities Q1 2020 · Dec 31, 2019 $16.96M
Current Assets Q1 2020 · Mar 31, 2020 $17.01M
Current Assets Q1 2020 · Dec 31, 2019 $31.24M
Total Assets Q1 2020 · Mar 31, 2020 $31.4M
Total Assets Q1 2020 · Dec 31, 2019 $46.37M
Sga Expense Q1 2020 · Mar 31, 2020 $7.22M
Sga Expense Q1 2020 · Mar 31, 2019 $5.41M
Rd Expense Q1 2020 · Mar 31, 2020 $9.45M
Rd Expense Q1 2020 · Mar 31, 2019 $16.17M
Net Income Q1 2020 · Mar 31, 2020 −$16.6M
Net Income Q1 2020 · Mar 31, 2019 −$21.02M
Operating Income Q1 2020 · Mar 31, 2020 −$16.67M
Operating Income Q1 2020 · Mar 31, 2019 −$21.58M